Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) EPS (Weighted Average and Diluted): 2011-2024

Historic EPS (Weighted Average and Diluted) for Niagen Bioscience (NAGE) over the last 6 years, with Dec 2024 value amounting to $0.11.

  • Niagen Bioscience's EPS (Weighted Average and Diluted) rose 150.00% to $0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.24, marking a year-over-year increase of 2019.81%. This contributed to the annual value of $0.11 for FY2024, which is 257.14% up from last year.
  • Niagen Bioscience's EPS (Weighted Average and Diluted) amounted to $0.11 in FY2024, which was up 257.14% from -$0.07 recorded in FY2023.
  • Niagen Bioscience's 5-year EPS (Weighted Average and Diluted) high stood at $0.11 for FY2024, and its period low was -$0.40 during FY2021.
  • Over the past 3 years, Niagen Bioscience's median EPS (Weighted Average and Diluted) value was -$0.07 (recorded in 2023), while the average stood at -$0.07.
  • In the last 5 years, Niagen Bioscience's EPS (Weighted Average and Diluted) dropped by 21.21% in 2021 and then surged by 257.14% in 2024.
  • Yearly analysis of 5 years shows Niagen Bioscience's EPS (Weighted Average and Diluted) stood at -$0.33 in 2020, then dropped by 21.21% to -$0.40 in 2021, then spiked by 40.00% to -$0.24 in 2022, then soared by 70.83% to -$0.07 in 2023, then surged by 257.14% to $0.11 in 2024.